|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Table 2: This table shows the process target and process capability (Cpm) for the 11 IMRT QA processes considered in this study against 3% and 5% clinical specifications. The last column of the table show the required clinical specification limit required to achieve Cpm = 1.33 (as a percent difference from the plan normalized dose) that would be required to reach an optimal performing process |